West Nile Virus Human IgG Assay Control BC141G

$96.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
West Nile Virus Human IgG Assay Control, recombinant
Applications: ELISA
Suitable for IgG detection
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC141G Category: Virion/Serion kits Tags: ELISA control serum, IgG, West Nile Virus

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	West Nile Virus reactive IgG
species reactivity	West Nile Virus
applications	ELISA
assay type	Indirect & quantitative
available size	1 mg

West Nile Virus Human IgG Assay Control BC141G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Form liquid
Associated products West Nile Virus Human IgG Assay Control (BC141G) West Nile Virus Human IgM Assay Control (BC141M) West Nile Virus IgG ELISA Kit (ESR141G) West Nile Virus IgM ELISA Kit (ESR141M)

target relevance

human antibody anti-West Nile Virus

West Nile Virus

Description
Virus that causes West Nile fever and neuroinvasive disease

Structure
West Nile virus (WNV) is an enveloped, positive-sense, single-stranded RNA virus belonging to the genus Flavivirus within the family Flaviviridae. The virus is closely related to other medically important flaviviruses, including Japanese encephalitis virus, St. Louis encephalitis virus, Dengue virus, and Zika virus. West Nile virus is maintained in nature through transmission cycles involving mosquitoes, primarily Culex species, and avian reservoir hosts. Humans and horses are considered incidental or dead-end hosts because they typically do not develop sufficient viremia to sustain transmission. Following mosquito-borne inoculation, the virus can disseminate to multiple tissues and, in some cases, invade the central nervous system. Since its introduction into North America in 1999, West Nile virus has become one of the most important mosquito-borne viral pathogens in the Western Hemisphere.

Diagnosis
The diagnosis of West Nile virus infection is performed through serological and molecular methods. Detection of West Nile virus-specific IgM antibodies in serum or cerebrospinal fluid using ELISA is the most commonly employed diagnostic approach and is particularly useful in patients with neurological disease. Confirmation may be obtained through plaque reduction neutralization testing (PRNT) to distinguish West Nile virus infection from other flaviviral infections. Reverse transcription polymerase chain reaction (RT-PCR) can detect viral RNA during the early phase of infection but is generally less sensitive because viremia is often transient and low-level. Cerebrospinal fluid analysis in neuroinvasive disease typically demonstrates lymphocytic pleocytosis and elevated protein concentrations. Laboratory confirmation is important because clinical symptoms overlap with numerous other viral infections and causes of encephalitis.

Symptoms
Approximately 80% of West Nile virus infections are asymptomatic. Symptomatic individuals typically develop illness following an incubation period of approximately two to fourteen days. West Nile fever commonly presents with fever, headache, fatigue, malaise, muscle aches, joint pain, nausea, vomiting, and occasionally a maculopapular rash. Most patients recover completely within days to weeks. A small proportion of infected individuals, particularly elderly or immunocompromised patients, develop neuroinvasive disease characterized by meningitis, encephalitis, or acute flaccid paralysis. Neurological manifestations may include severe headache, neck stiffness, confusion, altered mental status, tremors, seizures, muscle weakness, and paralysis. Severe neuroinvasive disease can result in long-term neurological deficits, respiratory failure, or death.

Data

FAQ & Publications

Frequently Asked Questions

What is the primary application of the West Nile Virus Human IgG Assay Control BC141G?

This product is primarily used as a control in ELISA applications for the detection of IgG antibodies against West Nile Virus.

How should the West Nile Virus Human IgG Assay Control BC141G be stored to maintain its stability?

The assay control should be stored refrigerated at 2-8°C to ensure its stability and effectiveness.

Is the West Nile Virus Human IgG Assay Control BC141G compatible with specific ELISA kits?

Yes, it is ready-to-use and pre-diluted specifically for compatibility with SERION ELISA classic and SERION ELISA antigen assays.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC141G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

West Nile Virus Human IgG Assay Control BC141G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Cytomegalovirus IgG Control Serum BC109G

Brucella IgG Control Serum BC116G

Enterovirus IgG Control Serum BC133G

Borrelia burgdorferi IgG Control Serum BC121G

Echovirus IgG Control Serum BC135G

Bordetella pertussis IgG Control Serum BC120G

Echinococcus IgG Control Serum BC107G

Aspergillus fumigatus IgG Control Serum BC132G

Diphtheria IgG Control Serum BC130G

Adenovirus IgG Control Serum BC128G

Coxsackie IgG Virus Control Serum BC134G

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G